Aneja Kritika, Gupta Alpa, Abraham Dax, Aggarwal Vivek, Sethi Simar, Chauhan Parul, Singh Arundeep, Kurian Ansy Hanna, Jala Sucheta
Department of Conservative Dentistry and Endodontics, Manav Rachna Dental College, Faridabad, Haryana, India.
Department of Conservative Dentistry and Endodontics, Jamia Milia Islamia, New Delhi, India.
J Dent Anesth Pain Med. 2022 Apr;22(2):75-86. doi: 10.17245/jdapm.2022.22.2.75. Epub 2022 Mar 25.
This review aims to identify the influence of the vehicle and its concentration used to carry calcium hydroxide (Ca(OH)) medicament on postoperative pain. The protocol for this review was registered in the open science framework (Registration DOI-10.17605/OSF.IO/4Y8A9) and followed the guidelines provided by the Joanna Briggs Institute. Reporting was based on the preferred reporting items for systematic reviews and meta-analyses extension for scoping reviews (PRISMA-ScR). Literature screening and searches were performed on PubMed/Medline, Scopus, and EBSCO hosts. Furthermore, additional records were manually analyzed using various sources. The selected studies were published in English and included the use of any vehicle adjunct to Ca(OH) to evaluate postoperative pain using qualitative and quantitative pain assessment tools. Descriptive analysis was conducted to review the study design, vehicle elements, and their effects. A preliminary search yielded 7584 studies, of which 10 were included. According to the data collected, the most commonly used Ca(OH) vehicles were chlorhexidine (CHX), normal saline, and camphorated paramonochlorophenol/glycerine (CPMC/glycerine), which had a significant effect on postoperative pain. Among the included studies, six evaluated the effect of CHX as a vehicle. It was observed that a higher concentration of the vehicle (2%) showed a favorable response in reducing postoperative pain. A majority of studies have validated a positive consequence of using a vehicle on postoperative pain. Although higher vehicle concentrations were found to alter postoperative pain levels, the data were insufficient to draw a firm conclusion. Our scoping review indicates that further clinical studies should focus on using different vehicles at various concentrations and application times to check for feasible and safe exposure in addition to providing pain relief.
本综述旨在确定用于运载氢氧化钙(Ca(OH))药物的载体及其浓度对术后疼痛的影响。本综述方案已在开放科学框架中注册(注册号DOI-10.17605/OSF.IO/4Y8A9),并遵循乔安娜·布里格斯研究所提供的指南。报告基于系统评价和Meta分析扩展的范围综述的首选报告项目(PRISMA-ScR)。在PubMed/Medline、Scopus和EBSCO主机上进行了文献筛选和检索。此外,还使用各种来源对其他记录进行了人工分析。所选研究以英文发表,包括使用任何作为Ca(OH)辅助剂的载体,使用定性和定量疼痛评估工具评估术后疼痛。进行描述性分析以审查研究设计、载体成分及其效果。初步检索得到7584项研究,其中10项被纳入。根据收集到的数据,最常用的Ca(OH)载体是洗必泰(CHX)、生理盐水和樟脑对氯苯酚/甘油(CPMC/甘油),它们对术后疼痛有显著影响。在所纳入的研究中,六项评估了CHX作为载体的效果。观察到较高浓度的载体(2%)在减轻术后疼痛方面显示出良好的反应。大多数研究证实了使用载体对术后疼痛有积极影响。尽管发现较高的载体浓度会改变术后疼痛水平,但数据不足以得出确凿结论。我们的范围综述表明,进一步的临床研究应侧重于使用不同浓度和应用时间的不同载体,除了缓解疼痛外,还要检查是否有可行且安全的暴露情况。